Global Tardive Dyskinesia Treatment Medicine Market Growth (Status and Outlook) 2026-2032
The global Tardive Dyskinesia Treatment Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary and repetitive movements, often affecting the face, tongue, lips, and other parts of the body. It is most commonly associated with the long-term use of certain medications, particularly antipsychotic medications used to treat conditions like schizophrenia and bipolar disorder. Tardive dyskinesia can be a challenging condition to manage, and treatment options aim to alleviate symptoms and improve the quality of life for affected individuals.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Tardive Dyskinesia Treatment Medicine Industry Forecast” looks at past sales and reviews total world Tardive Dyskinesia Treatment Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Tardive Dyskinesia Treatment Medicine sales for 2026 through 2032. With Tardive Dyskinesia Treatment Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tardive Dyskinesia Treatment Medicine industry.
This Insight Report provides a comprehensive analysis of the global Tardive Dyskinesia Treatment Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tardive Dyskinesia Treatment Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tardive Dyskinesia Treatment Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tardive Dyskinesia Treatment Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tardive Dyskinesia Treatment Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Tardive Dyskinesia Treatment Medicine market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary and repetitive movements, often affecting the face, tongue, lips, and other parts of the body. It is most commonly associated with the long-term use of certain medications, particularly antipsychotic medications used to treat conditions like schizophrenia and bipolar disorder. Tardive dyskinesia can be a challenging condition to manage, and treatment options aim to alleviate symptoms and improve the quality of life for affected individuals.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Tardive Dyskinesia Treatment Medicine Industry Forecast” looks at past sales and reviews total world Tardive Dyskinesia Treatment Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Tardive Dyskinesia Treatment Medicine sales for 2026 through 2032. With Tardive Dyskinesia Treatment Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tardive Dyskinesia Treatment Medicine industry.
This Insight Report provides a comprehensive analysis of the global Tardive Dyskinesia Treatment Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tardive Dyskinesia Treatment Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tardive Dyskinesia Treatment Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tardive Dyskinesia Treatment Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tardive Dyskinesia Treatment Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Tardive Dyskinesia Treatment Medicine market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
- Botulinum Toxin
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva Pharmaceutical
- Neurocrine Biosciences
- Sun Pharmaceutical
- SteriMax
- Adamas Pharmaceuticals (Supernus)
- AbbVie
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tardive Dyskinesia Treatment Medicine Market Size (2021-2032)
2.1.2 Tardive Dyskinesia Treatment Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tardive Dyskinesia Treatment Medicine by Country/Region (2021, 2025 & 2032)
2.2 Tardive Dyskinesia Treatment Medicine Segment by Type
2.2.1 Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
2.2.2 Botulinum Toxin
2.2.3 Others
2.2.4 Tardive Dyskinesia Treatment Medicine Market Size by Type
2.2.4.1 Tardive Dyskinesia Treatment Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
2.3 Tardive Dyskinesia Treatment Medicine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Tardive Dyskinesia Treatment Medicine Market Size by Application
2.3.4.1 Tardive Dyskinesia Treatment Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
3 TARDIVE DYSKINESIA TREATMENT MEDICINE MARKET SIZE BY PLAYER
3.1 Tardive Dyskinesia Treatment Medicine Market Size Market Share by Player
3.1.1 Global Tardive Dyskinesia Treatment Medicine Revenue by Player (2021-2026)
3.1.2 Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Player (2021-2026)
3.2 Global Tardive Dyskinesia Treatment Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARDIVE DYSKINESIA TREATMENT MEDICINE BY REGION
4.1 Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026)
4.2 Global Tardive Dyskinesia Treatment Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
4.4 APAC Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
4.5 Europe Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
4.6 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026)
5.2 Americas Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
5.3 Americas Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026)
6.2 APAC Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
6.3 APAC Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026)
7.2 Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
7.3 Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tardive Dyskinesia Treatment Medicine by Region (2021-2026)
8.2 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
8.3 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARDIVE DYSKINESIA TREATMENT MEDICINE MARKET FORECAST
10.1 Global Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.1.1 Global Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.1.2 Americas Tardive Dyskinesia Treatment Medicine Forecast
10.1.3 APAC Tardive Dyskinesia Treatment Medicine Forecast
10.1.4 Europe Tardive Dyskinesia Treatment Medicine Forecast
10.1.5 Middle East & Africa Tardive Dyskinesia Treatment Medicine Forecast
10.2 Americas Tardive Dyskinesia Treatment Medicine Forecast by Country (2027-2032)
10.2.1 United States Market Tardive Dyskinesia Treatment Medicine Forecast
10.2.2 Canada Market Tardive Dyskinesia Treatment Medicine Forecast
10.2.3 Mexico Market Tardive Dyskinesia Treatment Medicine Forecast
10.2.4 Brazil Market Tardive Dyskinesia Treatment Medicine Forecast
10.3 APAC Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.3.1 China Tardive Dyskinesia Treatment Medicine Market Forecast
10.3.2 Japan Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.3 Korea Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.4 Southeast Asia Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.5 India Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.6 Australia Market Tardive Dyskinesia Treatment Medicine Forecast
10.4 Europe Tardive Dyskinesia Treatment Medicine Forecast by Country (2027-2032)
10.4.1 Germany Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.2 France Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.3 UK Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.4 Italy Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.5 Russia Market Tardive Dyskinesia Treatment Medicine Forecast
10.5 Middle East & Africa Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.5.1 Egypt Market Tardive Dyskinesia Treatment Medicine Forecast
10.5.2 South Africa Market Tardive Dyskinesia Treatment Medicine Forecast
10.5.3 Israel Market Tardive Dyskinesia Treatment Medicine Forecast
10.5.4 Turkey Market Tardive Dyskinesia Treatment Medicine Forecast
10.6 Global Tardive Dyskinesia Treatment Medicine Forecast by Type (2027-2032)
10.7 Global Tardive Dyskinesia Treatment Medicine Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tardive Dyskinesia Treatment Medicine Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Information
11.1.2 Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
11.1.3 Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Teva Pharmaceutical Main Business Overview
11.1.5 Teva Pharmaceutical Latest Developments
11.2 Neurocrine Biosciences
11.2.1 Neurocrine Biosciences Company Information
11.2.2 Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Product Offered
11.2.3 Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Neurocrine Biosciences Main Business Overview
11.2.5 Neurocrine Biosciences Latest Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Information
11.3.2 Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
11.3.3 Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sun Pharmaceutical Main Business Overview
11.3.5 Sun Pharmaceutical Latest Developments
11.4 SteriMax
11.4.1 SteriMax Company Information
11.4.2 SteriMax Tardive Dyskinesia Treatment Medicine Product Offered
11.4.3 SteriMax Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 SteriMax Main Business Overview
11.4.5 SteriMax Latest Developments
11.5 Adamas Pharmaceuticals (Supernus)
11.5.1 Adamas Pharmaceuticals (Supernus) Company Information
11.5.2 Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Product Offered
11.5.3 Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Adamas Pharmaceuticals (Supernus) Main Business Overview
11.5.5 Adamas Pharmaceuticals (Supernus) Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Tardive Dyskinesia Treatment Medicine Product Offered
11.6.3 AbbVie Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tardive Dyskinesia Treatment Medicine Market Size (2021-2032)
2.1.2 Tardive Dyskinesia Treatment Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Tardive Dyskinesia Treatment Medicine by Country/Region (2021, 2025 & 2032)
2.2 Tardive Dyskinesia Treatment Medicine Segment by Type
2.2.1 Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
2.2.2 Botulinum Toxin
2.2.3 Others
2.2.4 Tardive Dyskinesia Treatment Medicine Market Size by Type
2.2.4.1 Tardive Dyskinesia Treatment Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
2.3 Tardive Dyskinesia Treatment Medicine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Tardive Dyskinesia Treatment Medicine Market Size by Application
2.3.4.1 Tardive Dyskinesia Treatment Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
3 TARDIVE DYSKINESIA TREATMENT MEDICINE MARKET SIZE BY PLAYER
3.1 Tardive Dyskinesia Treatment Medicine Market Size Market Share by Player
3.1.1 Global Tardive Dyskinesia Treatment Medicine Revenue by Player (2021-2026)
3.1.2 Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Player (2021-2026)
3.2 Global Tardive Dyskinesia Treatment Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARDIVE DYSKINESIA TREATMENT MEDICINE BY REGION
4.1 Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026)
4.2 Global Tardive Dyskinesia Treatment Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
4.4 APAC Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
4.5 Europe Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
4.6 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026)
5.2 Americas Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
5.3 Americas Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026)
6.2 APAC Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
6.3 APAC Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026)
7.2 Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
7.3 Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tardive Dyskinesia Treatment Medicine by Region (2021-2026)
8.2 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026)
8.3 Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARDIVE DYSKINESIA TREATMENT MEDICINE MARKET FORECAST
10.1 Global Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.1.1 Global Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.1.2 Americas Tardive Dyskinesia Treatment Medicine Forecast
10.1.3 APAC Tardive Dyskinesia Treatment Medicine Forecast
10.1.4 Europe Tardive Dyskinesia Treatment Medicine Forecast
10.1.5 Middle East & Africa Tardive Dyskinesia Treatment Medicine Forecast
10.2 Americas Tardive Dyskinesia Treatment Medicine Forecast by Country (2027-2032)
10.2.1 United States Market Tardive Dyskinesia Treatment Medicine Forecast
10.2.2 Canada Market Tardive Dyskinesia Treatment Medicine Forecast
10.2.3 Mexico Market Tardive Dyskinesia Treatment Medicine Forecast
10.2.4 Brazil Market Tardive Dyskinesia Treatment Medicine Forecast
10.3 APAC Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.3.1 China Tardive Dyskinesia Treatment Medicine Market Forecast
10.3.2 Japan Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.3 Korea Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.4 Southeast Asia Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.5 India Market Tardive Dyskinesia Treatment Medicine Forecast
10.3.6 Australia Market Tardive Dyskinesia Treatment Medicine Forecast
10.4 Europe Tardive Dyskinesia Treatment Medicine Forecast by Country (2027-2032)
10.4.1 Germany Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.2 France Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.3 UK Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.4 Italy Market Tardive Dyskinesia Treatment Medicine Forecast
10.4.5 Russia Market Tardive Dyskinesia Treatment Medicine Forecast
10.5 Middle East & Africa Tardive Dyskinesia Treatment Medicine Forecast by Region (2027-2032)
10.5.1 Egypt Market Tardive Dyskinesia Treatment Medicine Forecast
10.5.2 South Africa Market Tardive Dyskinesia Treatment Medicine Forecast
10.5.3 Israel Market Tardive Dyskinesia Treatment Medicine Forecast
10.5.4 Turkey Market Tardive Dyskinesia Treatment Medicine Forecast
10.6 Global Tardive Dyskinesia Treatment Medicine Forecast by Type (2027-2032)
10.7 Global Tardive Dyskinesia Treatment Medicine Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Tardive Dyskinesia Treatment Medicine Forecast
11 KEY PLAYERS ANALYSIS
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Information
11.1.2 Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
11.1.3 Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Teva Pharmaceutical Main Business Overview
11.1.5 Teva Pharmaceutical Latest Developments
11.2 Neurocrine Biosciences
11.2.1 Neurocrine Biosciences Company Information
11.2.2 Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Product Offered
11.2.3 Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Neurocrine Biosciences Main Business Overview
11.2.5 Neurocrine Biosciences Latest Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Information
11.3.2 Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
11.3.3 Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sun Pharmaceutical Main Business Overview
11.3.5 Sun Pharmaceutical Latest Developments
11.4 SteriMax
11.4.1 SteriMax Company Information
11.4.2 SteriMax Tardive Dyskinesia Treatment Medicine Product Offered
11.4.3 SteriMax Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 SteriMax Main Business Overview
11.4.5 SteriMax Latest Developments
11.5 Adamas Pharmaceuticals (Supernus)
11.5.1 Adamas Pharmaceuticals (Supernus) Company Information
11.5.2 Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Product Offered
11.5.3 Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Adamas Pharmaceuticals (Supernus) Main Business Overview
11.5.5 Adamas Pharmaceuticals (Supernus) Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Tardive Dyskinesia Treatment Medicine Product Offered
11.6.3 AbbVie Tardive Dyskinesia Treatment Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tardive Dyskinesia Treatment Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tardive Dyskinesia Treatment Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
Table 4. Major Players of Botulinum Toxin
Table 5. Major Players of Others
Table 6. Tardive Dyskinesia Treatment Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Table 9. Tardive Dyskinesia Treatment Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Table 12. Global Tardive Dyskinesia Treatment Medicine Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Player (2021-2026)
Table 14. Tardive Dyskinesia Treatment Medicine Key Players Head office and Products Offered
Table 15. Tardive Dyskinesia Treatment Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Table 20. Global Tardive Dyskinesia Treatment Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Tardive Dyskinesia Treatment Medicine Market Size Market Share by Country (2021-2026)
Table 24. Americas Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Table 26. Americas Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Table 28. APAC Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Table 30. APAC Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Country (2021-2026)
Table 34. Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Tardive Dyskinesia Treatment Medicine
Table 40. Key Market Challenges & Risks of Tardive Dyskinesia Treatment Medicine
Table 41. Key Industry Trends of Tardive Dyskinesia Treatment Medicine
Table 42. Global Tardive Dyskinesia Treatment Medicine Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Tardive Dyskinesia Treatment Medicine Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Tardive Dyskinesia Treatment Medicine Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Teva Pharmaceutical Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 47. Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
Table 48. Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Teva Pharmaceutical Main Business
Table 50. Teva Pharmaceutical Latest Developments
Table 51. Neurocrine Biosciences Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 52. Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Product Offered
Table 53. Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Neurocrine Biosciences Main Business
Table 55. Neurocrine Biosciences Latest Developments
Table 56. Sun Pharmaceutical Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 57. Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
Table 58. Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Sun Pharmaceutical Main Business
Table 60. Sun Pharmaceutical Latest Developments
Table 61. SteriMax Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 62. SteriMax Tardive Dyskinesia Treatment Medicine Product Offered
Table 63. SteriMax Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. SteriMax Main Business
Table 65. SteriMax Latest Developments
Table 66. Adamas Pharmaceuticals (Supernus) Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 67. Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Product Offered
Table 68. Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Adamas Pharmaceuticals (Supernus) Main Business
Table 70. Adamas Pharmaceuticals (Supernus) Latest Developments
Table 71. AbbVie Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 72. AbbVie Tardive Dyskinesia Treatment Medicine Product Offered
Table 73. AbbVie Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. AbbVie Main Business
Table 75. AbbVie Latest Developments
Table 1. Tardive Dyskinesia Treatment Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Tardive Dyskinesia Treatment Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
Table 4. Major Players of Botulinum Toxin
Table 5. Major Players of Others
Table 6. Tardive Dyskinesia Treatment Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Table 9. Tardive Dyskinesia Treatment Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Table 12. Global Tardive Dyskinesia Treatment Medicine Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Player (2021-2026)
Table 14. Tardive Dyskinesia Treatment Medicine Key Players Head office and Products Offered
Table 15. Tardive Dyskinesia Treatment Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Table 20. Global Tardive Dyskinesia Treatment Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Tardive Dyskinesia Treatment Medicine Market Size Market Share by Country (2021-2026)
Table 24. Americas Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Table 26. Americas Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Table 28. APAC Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Table 30. APAC Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Country (2021-2026)
Table 34. Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Tardive Dyskinesia Treatment Medicine
Table 40. Key Market Challenges & Risks of Tardive Dyskinesia Treatment Medicine
Table 41. Key Industry Trends of Tardive Dyskinesia Treatment Medicine
Table 42. Global Tardive Dyskinesia Treatment Medicine Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Tardive Dyskinesia Treatment Medicine Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Tardive Dyskinesia Treatment Medicine Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Teva Pharmaceutical Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 47. Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
Table 48. Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Teva Pharmaceutical Main Business
Table 50. Teva Pharmaceutical Latest Developments
Table 51. Neurocrine Biosciences Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 52. Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Product Offered
Table 53. Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Neurocrine Biosciences Main Business
Table 55. Neurocrine Biosciences Latest Developments
Table 56. Sun Pharmaceutical Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 57. Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Product Offered
Table 58. Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Sun Pharmaceutical Main Business
Table 60. Sun Pharmaceutical Latest Developments
Table 61. SteriMax Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 62. SteriMax Tardive Dyskinesia Treatment Medicine Product Offered
Table 63. SteriMax Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. SteriMax Main Business
Table 65. SteriMax Latest Developments
Table 66. Adamas Pharmaceuticals (Supernus) Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 67. Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Product Offered
Table 68. Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Adamas Pharmaceuticals (Supernus) Main Business
Table 70. Adamas Pharmaceuticals (Supernus) Latest Developments
Table 71. AbbVie Details, Company Type, Tardive Dyskinesia Treatment Medicine Area Served and Its Competitors
Table 72. AbbVie Tardive Dyskinesia Treatment Medicine Product Offered
Table 73. AbbVie Tardive Dyskinesia Treatment Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. AbbVie Main Business
Table 75. AbbVie Latest Developments
LIST OF FIGURES
Figure 1. Tardive Dyskinesia Treatment Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tardive Dyskinesia Treatment Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tardive Dyskinesia Treatment Medicine Sales Market Share by Country/Region (2025)
Figure 8. Tardive Dyskinesia Treatment Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type in 2025
Figure 10. Tardive Dyskinesia Treatment Medicine in Hospital
Figure 11. Global Tardive Dyskinesia Treatment Medicine Market: Hospital (2021-2026) & ($ millions)
Figure 12. Tardive Dyskinesia Treatment Medicine in Clinic
Figure 13. Global Tardive Dyskinesia Treatment Medicine Market: Clinic (2021-2026) & ($ millions)
Figure 14. Tardive Dyskinesia Treatment Medicine in Others
Figure 15. Global Tardive Dyskinesia Treatment Medicine Market: Others (2021-2026) & ($ millions)
Figure 16. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application in 2025
Figure 17. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Player in 2025
Figure 18. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Figure 19. Americas Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 20. APAC Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 21. Europe Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 23. Americas Tardive Dyskinesia Treatment Medicine Value Market Share by Country in 2025
Figure 24. United States Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region in 2025
Figure 29. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Figure 30. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Figure 31. China Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 35. India Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Country in 2025
Figure 38. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Figure 39. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Figure 40. Germany Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 41. France Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 54. APAC Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 55. Europe Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 57. United States Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 58. Canada Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 59. Mexico Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 60. Brazil Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 61. China Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 62. Japan Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 63. Korea Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 65. India Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 66. Australia Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 67. Germany Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 68. France Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 69. UK Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 70. Italy Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 71. Russia Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 72. Egypt Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 73. South Africa Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 74. Israel Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 75. Turkey Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 76. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 1. Tardive Dyskinesia Treatment Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Tardive Dyskinesia Treatment Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Tardive Dyskinesia Treatment Medicine Sales Market Share by Country/Region (2025)
Figure 8. Tardive Dyskinesia Treatment Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type in 2025
Figure 10. Tardive Dyskinesia Treatment Medicine in Hospital
Figure 11. Global Tardive Dyskinesia Treatment Medicine Market: Hospital (2021-2026) & ($ millions)
Figure 12. Tardive Dyskinesia Treatment Medicine in Clinic
Figure 13. Global Tardive Dyskinesia Treatment Medicine Market: Clinic (2021-2026) & ($ millions)
Figure 14. Tardive Dyskinesia Treatment Medicine in Others
Figure 15. Global Tardive Dyskinesia Treatment Medicine Market: Others (2021-2026) & ($ millions)
Figure 16. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application in 2025
Figure 17. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Player in 2025
Figure 18. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Figure 19. Americas Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 20. APAC Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 21. Europe Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size 2021-2026 ($ millions)
Figure 23. Americas Tardive Dyskinesia Treatment Medicine Value Market Share by Country in 2025
Figure 24. United States Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region in 2025
Figure 29. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Figure 30. APAC Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Figure 31. China Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 35. India Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Country in 2025
Figure 38. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Figure 39. Europe Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Figure 40. Germany Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 41. France Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Tardive Dyskinesia Treatment Medicine Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 54. APAC Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 55. Europe Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 57. United States Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 58. Canada Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 59. Mexico Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 60. Brazil Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 61. China Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 62. Japan Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 63. Korea Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 65. India Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 66. Australia Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 67. Germany Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 68. France Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 69. UK Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 70. Italy Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 71. Russia Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 72. Egypt Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 73. South Africa Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 74. Israel Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 75. Turkey Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
Figure 76. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Tardive Dyskinesia Treatment Medicine Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Tardive Dyskinesia Treatment Medicine Market Size 2027-2032 ($ millions)
